UBS Group’s Aurora Cannabis ACB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $495K | Buy |
177,561
+25,293
| +17% | +$84.6K | ﹤0.01% | 6234 |
|
|
2026
Q1 | $498K | Buy |
152,268
+60,198
| +65% | +$227K | ﹤0.01% | 6087 |
|
|
2025
Q4 | $389K | Sell |
92,070
-92,120
| -50% | -$450K | ﹤0.01% | 6231 |
|
|
2025
Q3 | $1.1M | Buy |
184,190
+106,391
| +137% | +$519K | ﹤0.01% | 5495 |
|
|
2025
Q2 | $330K | Sell |
77,799
-45,291
| -37% | -$219K | ﹤0.01% | 6367 |
|
|
2025
Q1 | $540K | Buy |
123,090
+60,551
| +97% | +$286K | ﹤0.01% | 5796 |
|
|
2024
Q4 | $266K | Buy |
62,539
+62,311
| +27,329% | +$306K | ﹤0.01% | 6281 |
|
|
2024
Q3 | $1.34K | Sell |
228
-58,278
| -100% | -$345K | ﹤0.01% | 8660 |
|
|
2024
Q2 | $270K | Buy |
58,506
+58,260
| +23,683% | +$369K | ﹤0.01% | 5451 |
|
|
2024
Q1 | $1.08K | Sell |
246
-197
| -44% | -$762 | ﹤0.01% | 8237 |
|
|
2023
Q4 | $2.11K | Sell |
443
-24,527
| -98% | -$118K | ﹤0.01% | 8164 |
|
|
2023
Q3 | $146K | Buy |
24,970
+24,148
| +2,938% | +$140K | ﹤0.01% | 5591 |
|
|
2023
Q2 | $4.4K | Sell |
822
-2,342
| -74% | -$13.8K | ﹤0.01% | 7539 |
|
|
2023
Q1 | $22.1K | Sell |
3,164
-4,973
| -61% | -$43.5K | ﹤0.01% | 7009 |
|
|
2022
Q4 | $74.9K | Buy |
8,137
+1,976
| +32% | +$23.6K | ﹤0.01% | 6376 |
|
|
2022
Q3 | $75K | Sell |
6,161
-19,914
| -76% | -$293K | ﹤0.01% | 5963 |
|
|
2022
Q2 | $343K | Buy |
26,075
+498
| +2% | +$12.5K | ﹤0.01% | 4552 |
|
|
2022
Q1 | $1.02M | Buy |
25,577
+5,439
| +27% | +$230K | ﹤0.01% | 4079 |
|
|
2021
Q4 | $1.09M | Sell |
20,138
-2,886
| -13% | -$194K | ﹤0.01% | 4315 |
|
|
2021
Q3 | $1.59M | Sell |
23,024
-592
| -3% | -$42.1K | ﹤0.01% | 3785 |
|
|
2021
Q2 | $2.13M | Buy |
23,616
+2,780
| +13% | +$241K | ﹤0.01% | 3519 |
|
|
2021
Q1 | $1.94M | Buy |
20,836
+629
| +3% | +$70.3K | ﹤0.01% | 3591 |
|
|
2020
Q4 | $1.68M | Buy |
20,207
+9,906
| +96% | +$722K | ﹤0.01% | 3557 |
|
|
2020
Q3 | $480K | Buy |
10,301
+485
| +5% | +$46.1K | ﹤0.01% | 4227 |
|
|
2020
Q2 | $1.22M | Buy |
9,816
+8,770
| +838% | +$998K | ﹤0.01% | 3333 |
|
|
2020
Q1 | $114K | Buy |
1,046
+376
| +56% | +$67.2K | ﹤0.01% | 5175 |
|
|
2019
Q4 | $174K | Sell |
670
-1,649
| -71% | -$615K | ﹤0.01% | 5688 |
|
|
2019
Q3 | $1.22M | Buy |
2,319
+1,661
| +252% | +$1.23M | ﹤0.01% | 3785 |
|
|
2019
Q2 | $618K | Buy |
658
+222
| +51% | +$223K | ﹤0.01% | 4133 |
|
|
2019
Q1 | $473K | Buy |
436
+24
| +6% | +$21.5K | ﹤0.01% | 4101 |
|
|
2018
Q4 | $245K | Buy |
+412
| New | +$304K | ﹤0.01% | 4804 |
|
Other funds holding ACB
TI
AI
SC
UBS Group's ACB Position: Q2 2026 in Review
UBS Group increased its Aurora Cannabis (ACB) stake by 17% in Q2 2026, buying an estimated $84.6K and bringing the position to 177,561 shares worth $495K. The position accounts for ﹤0.01% of the portfolio, ranked #6234.
UBS Group first reported a position in ACB in Q4 2018 and has held it in 31 quarters since. The position peaked at $2.13M in Q2 2021. 149 funds tracked by Wall St. Rank hold ACB as of Q2 2026.
- UBS Group held 177,561 shares of Aurora Cannabis worth $495K as of Q2 2026.
- UBS Group bought 25,293 Aurora Cannabis shares in Q2 2026, an estimated $84.6K.
- Aurora Cannabis made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #6234 holding.
- UBS Group first reported a position in Aurora Cannabis in Q4 2018 and has held it in 31 quarters since.
- UBS Group's Aurora Cannabis position peaked at $2.13M in Q2 2021.
- 149 funds tracked by Wall St. Rank held Aurora Cannabis as of Q2 2026.
Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.